Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY

v3.23.1
STOCKHOLDERS' EQUITY
 3 Months Ended
Jun. 30, 2022
Equity [Abstract]  
Stockholder's Equity STOCKHOLDERS’ EQUITY
During the three months ended June 30, 2022, and 2021, no outstanding non-qualified stock options were exercised.

In May 2022 Freedom KZ completed the acquisition of two insurance companies, Freedom Life and Freedom Insurance. These two companies were 100% controlled by the Company’s chief executive officer, chairman and majority shareholder, Timur Turlov. The consideration for closing of the sale was $26,588.

During the three months ended June 30, 2022, Timur Turlov made a capital contribution to the Company in amount of $677.

On March 30, 2022, the Company awarded a restricted stock grant totaling 7,500 shares of its common stock to one executive officer of the Company. Of the 7,500 shares awarded pursuant to the restricted stock grant awards, 3,000 shares vest on May 18, 2023, 1,500 shares vest on May 18, 2024, 1,500 shares vest on May 18, 2025 and 1,500 shares vest on May 18, 2026.
On May 18, 2021, the Company awarded restricted stock grants totaling 1,031,500 shares of its common stock to 56 employees and consultants of the Company, including two executive officers of the Company. Of the 1,031,500 shares awarded pursuant to the restricted stock grant awards, 200,942 shares are subject to one-year vesting, 211,658 shares are subject to two-year vesting and 206,300 shares per year are subject to three, four and five-year vesting schedule, respectively.
The Company recorded stock-based compensation expense for restricted stock grants and stock options in the amount of $3,697 during the three months ended June 30, 2022. During the three months ended June 30, 2021, the Company recorded stock-based compensation expense for restricted stock grants and stock options in the amount of $2,162.